SEC Form 4 · accession 0001415889-16-006514
INNOVUS PHARMACEUTICALS, INC. · INNV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vivian H Liu
Director
Period of report
Apr 1, 2016
Accepted (ET)
Jul 15, 2016 · 9:50 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001411879
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1 | — | Apr 1, 2016 | A | 44,709 | A | Apr 1, 2016 | Apr 1, 2026 | Common Stock | 44,709 | 582,241 | D |
| Restricted Stock UnitsF1 | — | Apr 1, 2016 | A | 44,709 | A | Jul 1, 2016 | Jul 1, 2026 | Common Stock | 13,825 | 596,066 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, at settlement, one share of common stock.